AGENUS INC — Director's Dealing 2010

Oct 28, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANTIGENICS INC /DE/ (AGEN)
CIK: 0001098972
Period of Report: 2010-10-26

Reporting Person: Sharp Shalini (CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-10-26	Common Stock	A	3750	$0.98	Acquired	168245	Direct
2010-10-28	Common Stock	S	1500	$0.96	Disposed	166745	Direct

Footnotes

F1: Represents settlement of restricted stock which was awarded on January 26, 2010.

F2: Represents shares sold to cover minimum federal, state and local tax withholding requirements upon the vesting of the restricted stock awarded on January 26, 2010. This sale has been made in accordance with a 10b5-1 trading plan.